Endocrine Disruptors as a New Regulatory Endpoint

Abstract

The U.S. Environmental Protection Agency (U.S. EPA) has been mandated in the 1996 Food Quality Protection Act and 1996 Safe Drinking Water Act Amendments to develop and implement a screening and testing program for endocrine disruptors. U.S. EPA’s recent regulatory activities are summarized, and predictions are made on how U.S. EPA’s drinking water regulatory framework may change to reflect potential short-term (reproductive and developmental) endpoints. A case study using simulated monitoring data is used to show how drinking water monitoring and compliance time frame may change to address the potential adverse health endpoints.